Connor, Clark & Lunn Investment Management Ltd. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$97,000
-63.0%
25,996
-66.1%
0.00%
-100.0%
Q4 2020$262,000
-69.7%
76,745
-70.0%
0.00%
-66.7%
Q2 2020$865,000
+8.0%
255,880
-25.6%
0.01%
-14.3%
Q1 2020$801,000
+8.5%
343,874
+69.5%
0.01%
+40.0%
Q4 2019$738,000
-57.3%
202,825
-2.7%
0.01%
-58.3%
Q3 2019$1,728,000
+13.3%
208,350
+17.6%
0.01%
+20.0%
Q2 2019$1,525,000
+400.0%
177,125
+520.4%
0.01%
+400.0%
Q1 2019$305,000
-64.2%
28,550
-43.8%
0.00%
-60.0%
Q3 2018$853,000
+21.2%
50,790
-53.1%
0.01%0.0%
Q1 2017$704,000
-21.6%
108,304
-46.6%
0.01%
-16.7%
Q4 2016$898,000
-9.4%
202,700
-4.5%
0.01%
-14.3%
Q3 2016$991,000
-54.9%
212,300
-36.5%
0.01%
-56.2%
Q2 2016$2,195,000
-18.2%
334,100
-20.8%
0.02%
-23.8%
Q1 2016$2,682,000
-27.5%
421,725
-31.3%
0.02%
-32.3%
Q4 2015$3,700,000
+62.7%
613,525
+61.3%
0.03%
+72.2%
Q3 2015$2,274,000
+771.3%
380,300
+898.2%
0.02%
+800.0%
Q2 2015$261,000
+36.6%
38,100
+21.3%
0.00%0.0%
Q1 2015$191,000
+5.5%
31,400
+20.3%
0.00%
+100.0%
Q4 2014$181,00026,1000.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders